ADVERTISEMENT
Search
Login JOIN / RENEW

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Electronic prompts could improve antibiotic selection for pneumonia Electronic prompts could improve antibiotic selection for pneumonia

Electronic prompts could improve antibiotic selection for pneumonia

0 614

Pneumonia remains the most common infection-related condition that lands U.S. patients in the hospital. Identifying strategies to curb antibiotic overuse for those hospitalized with pneumonia continues to be a national priority.

Semaglutide yields positive results for patients with obesity-related... Semaglutide yields positive results for patients with obesity-related...

Semaglutide yields positive results for patients with obesity-related...

0 948
Results of a new study published in NEJM found that semaglutide led to greater reductions in weight loss and heart failure–related symptoms in patients who had obesity-related heart failure with preserved ejection fraction and T2D compared with placebo.
Does biosimilar competition lower costs for patients? Does biosimilar competition lower costs for patients?

Does biosimilar competition lower costs for patients?

Biosimilars have typically been viewed as cost-saving medications, but according to results of a study published in JAMA Health Forum, biosimilar...
0 753
D-Mannose appears ineffective for UTI prevention D-Mannose appears ineffective for UTI prevention

D-Mannose appears ineffective for UTI prevention

Authors of a new study said that “d-Mannose should not be recommended to prevent future episodes of medically attended UTI in women with...
0 824
Study links heart failure risk to e-cigarette use Study links heart failure risk to e-cigarette use

Study links heart failure risk to e-cigarette use

Data from an NIH-led study found that people who used e-cigarettes were 19% more likely to develop heart failure compared with people who never...
0 1056
Loneliness tops social determinants of health, says survey Loneliness tops social determinants of health, says survey

Loneliness tops social determinants of health, says survey

Survey results published in CDC’s Morbidity and Mortality Weekly Report (MMWR) found that social isolation or loneliness and lack of social...
0 707

HHS releases new smoking cessation framework

HHS wants to accelerate smoking cessation and reduce smoking- and cessation-related disparities. The agency unveiled a new framework with six goals to help drive progress toward cessation and specifically focused on combusted tobacco products, like cigarettes, among people of all ages.

FDA approves semaglutide to reduce CV risk

FDA announced the decision to approve the GLP-1 receptor agonist, semaglutide (Wegovy), to reduce the risk of CV death, heart attack, and stroke in adults with CVD and obesity or overweight.

245678910Last
ADVERTISEMENT